G-Protein Coupled Estrogen Receptor in Breast Cancer

Li Han Hsu, Nei Min Chu, Yung Feng Lin, Shu Huei Kao

研究成果: 雜誌貢獻回顧型文獻同行評審

56 引文 斯高帕斯(Scopus)


The G-protein coupled estrogen receptor (GPER), an alternate estrogen receptor (ER) with a structure distinct from the two canonical ERs, being ERα, and ERβ, is expressed in 50% to 60% of breast cancer tissues and has been presumed to be associated with the development of tamoxifen resistance in ERα positive breast cancer. On the other hand, triple-negative breast cancer (TNBC) constitutes 15% to 20% of breast cancers and frequently displays a more aggressive behavior. GPER is prevalent and involved in TNBC and can be a therapeutic target. However, contradictory results exist regarding the function of GPER in breast cancer, proliferative or pro-apoptotic. A better understanding of the GPER, its role in breast cancer, and the interactions with the ER and epidermal growth factor receptor will be beneficial for the disease management and prevention in the future.
期刊International Journal of Molecular Sciences
出版狀態已發佈 - 1月 14 2019

ASJC Scopus subject areas

  • 催化
  • 分子生物學
  • 光譜
  • 電腦科學應用
  • 物理與理論化學
  • 有機化學
  • 無機化學


深入研究「G-Protein Coupled Estrogen Receptor in Breast Cancer」主題。共同形成了獨特的指紋。